Venetoclax In Combination with ASTX727, an All-ORal TherapY for Chronic Myelomonocytic Leukemia and Other MDS/MPN with Excess Blasts VICTORY-MDS/MPN: a Randomized, Phase II trial

Brief Summary

Type:
Myelodysplastic Syndrome

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05600894

Study #:
STUDY00150278

Start Date:
Jun 21, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05600894

View Complete Trial Details & Eligibility at ClinicalTrials.gov